PATENT CLAIM ANALYSIS

Application Number: 16031819
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["435", "440000"]

Abstract:
Compositions and methods for using nucleosome interacting protein domains to increase accessibility of programmable DNA modification proteins to target chromosomal sequences, thereby increasing efficiency of targeted genome/epigenetic modification in eukaryotic cells.

Claim (Index 10):
The fusion protein of  claim 1 , wherein the CRISPR protein is  Streptococcus pyogenes  Cas9 (SpCas9),  Streptococcus thermophilus  Cas9 (StCas9),  Streptococcus pasteurianus  (SpaCas9),  Campylobacter jejuni  Cas9 (CjCas9),  Staphylococcus aureus  (SaCas9),  Francisella novicida  Cas9 (FnCas9),  Neisseria cinerea  Cas9 (NcCas9), or  Neisseria  meningitis Cas9 (NmCas9).

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.1
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15437148', '14105017', '15179912', '15935334', '15369533']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5970864157097583
- 35 USC 102 Novelty (BERT): 0.5371813408672406
- Combined Prediction Score: 0.5910959082255066
- Mean Citation Score: 363.518024
- Max Citation Score: 385.41925
- Similarity Product: 287.57658259335165

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test